对于新兴的生物制药和生物技术公司在当今充满挑战的环境中表现出色,至关重要的是要深入了解从临床到商业的整个旅程中对患者的概况和市场动态的了解。IQVIA资产最大化器是一套全面的解决方案套件,由专门致力于您的专家提供,以帮助您的突破更快。
Asset success starts early for pharmaceutical companies with a need to ensure clinical trial design considers endpoints that demonstrate value to regulators, payers, prescribers, and the patient. Communicating that value requires an adaptable, omnichannel approach to activate and engage all stakeholders at launch and throughout the product lifecycle. Work with IQVIA, the global leader in clinical development, Real World Evidence, and the commercialization of new treatments to deliver a winning asset at launch and beyond.
IQVIA为临床和商业客户建立了联系,以将疗法推向市场以及需要它们的患者。
立即取得联系,为您找到正确的解决方案。